Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Detection method of hepatitis B virus genome drug resistance mutation

A technology of hepatitis B virus and mutant type, which is applied in biochemical equipment and methods, and microbial measurement/inspection, etc., can solve the problems of cumbersome operation, high cost, and unfavorable development of primary hospitals, so as to improve the diffusion rate and simple operation Effect

Active Publication Date: 2006-06-14
上海达安医学检验所有限公司
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, most of these methods are expensive and cumbersome to operate, which is not conducive to the development of primary hospitals.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Detection method of hepatitis B virus genome drug resistance mutation
  • Detection method of hepatitis B virus genome drug resistance mutation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0090] Embodiment 1: the extraction of serum DNA

[0091] Aseptically collect about 1ml of venous blood from the hepatitis B patient to be tested, let it stand at room temperature and 4°C for 2 hours and 1 hour respectively, then centrifuge (8,000rpm, 5 minutes) to separate and collect 200μl of serum sample. Then take 40 μl of serum sample, add an equal amount of DNA extraction solution to it, mix thoroughly and place in a boiling water bath for 10 minutes. In order to ensure that the virus particles contained in the serum can be fully lysed, the mixture was further left to stand at 4° C. for 10 hours. It was then centrifuged (10,000 rpm, 5 minutes) and 2 μl of the supernatant was collected and used for further PCR reactions.

Embodiment 2

[0092] Embodiment 2: PCR amplification of the fragment comprising YMDD motif

[0093] Take several tubes of single-person PCR reaction solution, add 1 μl UDG enzyme to each tube, and then directly add 2 μl template (or negative and positive standards), mix well and then centrifuge briefly (3 seconds). Then put each reaction tube into the PCR instrument, pretreat at 50°C for 3 minutes, and amplify according to the following conditions: 94°C for 5 minutes, then press 93°C for 30 seconds, 55°C for 30 seconds, and 72°C for 40 seconds, a total of 35 cycles, A final 72°C extension was performed for 7 minutes. The amplified products were detected by 2% agarose gel electrophoresis (see attached figure 1 ). The PCR amplification system used included: 1×qualitative PCR buffer, 0.2 mM dNTPs, 2 U Taq enzyme, 0.2 μM primers 1 (SEQ ID NO: 1) and 2 (SEQ ID NO: 2).

Embodiment 3

[0094] Example 3: Reverse dot blot detection of samples of three known genotypes

[0095]Before hybridization, preheat hybridization solution I (2×SSC-0.1% SDS) and hybridization solution II to 44°C for use. Take three 1.5ml centrifuge tubes according to the number of samples to be tested, add 0.5ml hybridization solution I to each tube and preheat to 44°C. After the PCR amplification product was denatured at 95° C. for 10 minutes, it was placed in an ice-water mixture for 4 minutes. Then take 1000 μl hybridization solution I+2 μl solution I (1000:2) mixed solution as the binding solution and store it at 4°C for later use, and take the mixture of solution II: solution III: solution IV (1900:200:1) (1.9ml solution II+ 0.2ml of solution III + 1 μl of solution IV) is used as a chromogenic solution and stored away from light for later use.

[0096] Before hybridization, fill the reaction chamber with distilled water, place the metal perforated plate, and turn on the negative pre...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to examination mutant hepatitis virus method, especially the method of using DNA reverse dot blot hybridization technique to quickly and exactly distinguish clinic blood sample wild type and rummy fuding tolerance mutant hepatitis b virus. And it also relates to clinic measuring kit.

Description

field of invention [0001] The invention relates to a method for detecting mutant hepatitis B virus, in particular to a method for quickly and accurately distinguishing wild-type and lamivudine-resistant mutant hepatitis B virus in clinical blood samples by using DNA reverse dot hybridization technology. The invention further relates to kits for this clinical assay. Background of the invention [0002] Hepatitis B virus (HBV) is the main pathogen causing viral hepatitis. Hepatitis B caused by HBV is a serious infectious disease. At present, there are at least 350 million chronic HBV-infected persons in the world, and China, as a high prevalence area of ​​hepatitis B, has about 9% of the total population (about 120 million) as chronic HBV-infected persons. Persistent chronic HBV infection can be clinically manifested as various types of diseases, including asymptomatic carrier status, acute or chronic hepatitis, liver cirrhosis, etc., and severe cases may develop into primar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68
Inventor 王伟毅欧志英何蕴韶程钢
Owner 上海达安医学检验所有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com